LENZ Therapeutics, Inc.
Recent Filings
All 327 filings →| Form | Description | Date |
|---|---|---|
| S-8 | S-8 | Mar 24, 2026 |
| 8-K | 8-K | Mar 24, 2026 |
| 10-K | 10-K | Mar 24, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 5, 2026 |
| SCHEDULE 13G/A | — | Jan 21, 2026 |
| 8-K | 8-K | Jan 7, 2026 |
| 4 | FORM 4 | Jan 6, 2026 |
| 4 | FORM 4 | Jan 6, 2026 |
| 4 | FORM 4 | Jan 6, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| Olsson Shawn | Chief Commercial Officer | Sale | 5,788 @ $26.37 | Nov 17, 2025 |
| MCCOLLUM JAMES W | — | Purchase | 10,500 @ $22.79 | Nov 7, 2025 |
| Chevallard Daniel R. | Chief Financial Officer | Purchase | 20 @ $22.71 | Nov 7, 2025 |
| Versant Vantage II GP-GP, LLC | — | Sale | 123 @ $47.01 | Sep 30, 2025 |
| Versant Venture Capital VI, L.P. | — | Sale | 40,907 @ $43.00 | Sep 18, 2025 |
| Versant Ventures VII GP, L.P. | — | Sale | 10,076 @ $40.03 | Aug 26, 2025 |
| Versant Venture Capital VI, L.P. | — | Sale | 145,051 @ $39.50 | Aug 15, 2025 |
| Versant Ventures VII GP-GP, LLC | — | Sale | 191,376 @ $34.00 | Jul 10, 2025 |
| Versant Vantage II GP-GP, LLC | — | Sale | 200,000 @ $30.47 | Jun 27, 2025 |
| Versant Ventures VI GP, L.P. | — | Sale | 133,924 @ $30.25 | Jun 20, 2025 |